Evidence map›Paper›PMID 38852064›Full record

ArticleTransplant infectious disease : an official journal of the Transplantation Society2024

Hospitalizations for opportunistic infections following transplantation and associated risk factors: A national cohort study of Medicare beneficiaries.

Alyssa K Mezochow, Douglas E Schaubel, Eliot G Peyster, James D Lewis, David S Goldberg, Therese Bittermann

Abstract read
In one paragraph

Article in Transplant infectious disease : an official journal of the Transplantation Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alyssa K MezochowDepartment of Infectious Diseases, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0000-0002-0838-2627
Douglas E SchaubelDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Eliot G PeysterAdvanced Heart Failure and Transplant Medicine, Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
James D LewisDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David S GoldbergDivision of Digestive Health & Liver Diseases, Miller School of Medicine, University of Miami, Miami, Florida, USA.
Therese BittermannDepartment of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Funding

TRANSGENIC AND CHIMERIC MOUSE COREP30DK050306 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI REBECCA G WELLS · 1997 to 2026
$32.5M
Infectious Diseases Epidemiology Training GrantT32AI055435 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAUTENBACH, EBBING · 2003 to 2023
$6.9M
Survival Analysis Methods for Organ Failure DataR01DK070869 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI DOUGLAS EARL SCHAUBEL · 2005 to 2026
$4.7M
Impact of mammalian target of rapamycin inhibitor therapy on aging-related outcomesR01AG079911 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David E Kaplan, DOUGLAS EARL SCHAUBEL · 2023 to 2026
$1.6M
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)R01AA030963 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI Marina Serper · 2023 to 2026
$1.6M
Impact of immunosuppression variability on outcomes after liver transplantationK08DK117013 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI BITTERMANN, THERESE · 2018 to 2022
$932k
Personalized Rejection Risk Assessment in Cardiac TransplantationK08HL159344 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI PEYSTER, ELIOT · 2021 to 2024
$667k
NHLBI NIH HHS K08 HL159344NIAAA NIH HHS R01 AA030963NIAID NIH HHS T32 AI055435NIA NIH HHS R01 AG079911NIDDK NIH HHS K08 DK117013NIDDK NIH HHS P30 DK050306NIDDK NIH HHS R01 DK070869
6 · The paper itself

Abstract

backgroundOpportunistic infections (OIs) are a significant cause of morbidity and mortality after organ transplantation, though data in the liver transplant (LT) population are limited.

methodsWe performed a retrospective cohort study of LT recipients between January 1, 2007 and Deceber 31, 2016 using Medicare claims data linked to the Organ Procurement and Transplantation Network database. Multivariable Cox regression models evaluated factors independently associated with hospitalizations for early (≤1 year post transplant) and late (>1 year) OIs, with a particular focus on immunosuppression.

resultsThere were 11 320 LT recipients included in the study, of which 13.2% had at least one OI hospitalization during follow-up. Of the 2638 OI hospitalizations, 61.9% were early post-LT. Cytomegalovirus was the most common OI (45.4% overall), although relative frequency decreased after the first year (25.3%). Neither induction or maintenance immunosuppression were associated with early OI hospitalization (all p > .05). The highest risk of early OI was seen with primary sclerosing cholangitis (aHR 1.74; p = .003 overall). Steroid-based and mechanistic target of rapamycin inhibitor-based immunosuppression at 1 year post LT were independently associated with increased late OI (p < .001 overall).

conclusionThis study found OI hospitalizations to be relatively common among LT recipients and frequently occur later than previously reported. Immunosuppression regimen may be an important modifiable risk factor for late OIs.

Indexed as

HospitalizationLiver TransplantationMedicareOpportunistic InfectionsAgedCytomegalovirus InfectionsFemaleHumansImmunosuppression TherapyImmunosuppressive AgentsMaleMiddle AgedRetrospective StudiesRisk FactorsUnited StatesImmunosuppressive Agents

Identifiers

PMID38852064
PMCPMC11315637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.